TriSalus Life Sciences, Inc. Basic Shares Outstanding (Weighted Average)
TriSalus Life Sciences, Inc. (TLSI) reported Basic Shares Outstanding (Weighted Average) of 58.30 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-06
- TriSalus Life Sciences, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 58.30M shares, a 77.20% increase year-over-year.
- TriSalus Life Sciences, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 51.54M shares, a 80.67% increase year-over-year.
- TriSalus Life Sciences, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 47.02M shares, a 70.59% increase year-over-year.
- TriSalus Life Sciences, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 43.06M shares, a 62.47% increase year-over-year.
- TriSalus Life Sciences, Inc. weighted average number of shares outstanding, basic for fiscal 2025 was 37.90M shares, a 49.61% increase from fiscal 2024.
- TriSalus Life Sciences, Inc. weighted average number of shares outstanding, basic for fiscal 2024 was 25.33M shares, a 169.61% increase from fiscal 2023.
- TriSalus Life Sciences, Inc. weighted average number of shares outstanding, basic for fiscal 2023 was 9.40M shares, a 2934.71% increase from fiscal 2022.
- TriSalus Life Sciences, Inc. weighted average number of shares outstanding, basic for fiscal 2022 was 309.61K shares.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | 58.30M shares 10-Q · filed 2026-08-06 | 54.94M shares 10-Q · filed 2026-08-06 | 52.28M shares derived: average of 3 quarters · filed 2026-08-06 | 49.98M shares derived: average of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | 51.54M shares 10-Q · filed 2026-05-12 | 49.28M shares derived: average of 2 quarters · filed 2026-05-12 | 47.20M shares derived: average of 3 quarters · filed 2026-05-12 | 43.63M shares derived: average of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | 47.02M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | 45.04M shares derived: average of 2 quarters · filed 2026-03-05 | 40.99M shares derived: average of 3 quarters · filed 2026-08-06 | 37.90M shares 10-K · filed 2026-03-05 |
| 2025-09-30 | 43.06M shares 10-Q · filed 2025-11-13 | 37.98M shares derived: average of 2 quarters · filed 2026-08-06 | 34.86M shares 10-Q · filed 2025-11-13 | 33.01M shares derived: average of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | 32.90M shares 10-Q · filed 2026-08-06 | 30.71M shares 10-Q · filed 2026-08-06 | 29.66M shares derived: average of 3 quarters · filed 2026-08-06 | 28.87M shares derived: average of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | 28.53M shares 10-Q · filed 2026-05-12 | 28.04M shares derived: average of 2 quarters · filed 2026-05-12 | 27.53M shares derived: average of 3 quarters · filed 2026-05-12 | 26.62M shares derived: average of 4 quarters · filed 2026-05-12 |
| 2024-12-31 | 27.56M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | 27.03M shares derived: average of 2 quarters · filed 2026-03-05 | 25.99M shares derived: average of 3 quarters · filed 2026-03-05 | 25.33M shares 10-K · filed 2026-03-05 |
| 2024-09-30 | 26.50M shares 10-Q · filed 2025-11-13 | 25.20M shares derived: average of 2 quarters · filed 2025-11-13 | 24.59M shares 10-Q · filed 2025-11-13 | 24.27M shares derived: average of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | 23.90M shares 10-Q · filed 2025-08-12 | 23.61M shares 10-Q · filed 2025-08-12 | 23.52M shares derived: average of 3 quarters · filed 2025-08-12 | 20.93M shares derived: average of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | 23.32M shares 10-Q · filed 2025-05-15 | 23.33M shares derived: average of 2 quarters · filed 2025-05-30 | 19.94M shares derived: average of 3 quarters · filed 2025-05-30 | 15.07M shares derived: average of 4 quarters · filed 2025-05-30 |
| 2023-12-31 | 23.33M shares derived: 10-K/A 12 month − 10-Q 9 month · filed 2025-05-30 | 18.25M shares derived: average of 2 quarters · filed 2025-05-30 | 12.32M shares derived: average of 3 quarters · filed 2025-05-30 | 9.40M shares 10-K/A · filed 2025-05-30 |
| 2023-09-30 | 13.17M shares 10-Q · filed 2024-11-14 | 6.81M shares derived: average of 2 quarters · filed 2024-11-14 | 4.75M shares 10-Q · filed 2024-11-14 | 7.53M shares derived: average of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | 446.29K shares 10-Q · filed 2024-08-14 | 421.86K shares 10-Q · filed 2024-08-14 | 5.65M shares derived: average of 3 quarters · filed 2024-08-14 | 4.32M shares derived: average of 4 quarters · filed 2024-08-14 |
| 2023-03-31 | 16.17M shares 10-Q · filed 2024-05-15 | 8.25M shares derived: average of 2 quarters · filed 2024-05-15 | 5.61M shares derived: average of 3 quarters · filed 2024-05-15 | |
| 2022-12-31 | 338.63K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-11 | 325.23K shares derived: average of 2 quarters · filed 2024-04-11 | 309.61K shares 10-K · filed 2024-04-11 | |
| 2022-09-30 | 311.82K shares 10-Q · filed 2023-11-14 | 299.94K shares 10-Q · filed 2023-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |